Rating Change
Argus Research reiterated its Buy rating on CVS Health Corporation (NYSE:CVS) on August 19, 2026.
reiterateNYSE:CVS
Argus Research Reiterates Buy Rating on CVS Health Corporation (CVS)
Argus Research reiterated its Buy rating on CVS Health Corporation (NYSE:CVS) on August 19, 2026.
At publication ·
What changed
CVS Health Corporation (NYSE:CVS) · reiterate
- Firm
- Argus Research
- Rating
- Buy to Buy
- Price at event
- $93.65
- Market capitalization
- $102.6B
At a glance
Key takeaways
- Argus Research reiterated a Buy rating on CVS Health Corporation on August 19, 2026, with the stock trading at $93.65 and a market capitalization of $102.6 billion.
Market Context
CVS Health Corporation operates in the Healthcare sector. The stock currently trades at $93.65 with a market capitalization of $102.6B. The stock has gained 16.5% over the past 52 weeks.
Analyst coverage from Argus Research provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CVS Health Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CVS Health Corporation
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 19, 2026 | Argus Research | Buy | N/A |
| Aug 12, 2026 | JP Morgan | Overweight | N/A |
| Aug 06, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 06, 2026 | UBS | Buy | N/A |
| Aug 06, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View CVS Stock Page
Frequently Asked Questions
What does the Buy rating mean for CVS?
A rating of Buy from Argus Research reflects the analyst's outlook on CVS Health Corporation (NYSE:CVS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CVS forecast page.